1. 2019
  2. Evaluating a Single Domain Antibody Targeting Human PD-L1 as a Nuclear Imaging and Therapeutic Agent

    Broos, K., Lecocq, Q., Xavier, C., Bridoux, J., Nguyen, T., Corthals, J., Schoonooghe, S., Lion, E., Raes, G., Keyaerts, M., Devoogdt, N. & Breckpot, K., 21 Jun 2019, In : Cancers. 11, 6, 19 p., 872.

    Research output: Contribution to journalArticleResearchpeer-review

  3. Poster presentation. Phase II trial of HER2-PET/CT using 68Ga-anti-HER2 VHH1 for characterization of HER2 presence in brain metastases of breast cancer patients

    Keyaerts, M., Xavier, C., Everaert, H., Vaneycken, I., Fontaine, C., Decoster, L., Vanhoeij, M., Caveliers, V. & Lahoutte, T., 1 May 2019, In : Annals of Oncology. 30, (suppl_3): iii1-iii26. 10.1093/annonc/mdz095, 85TiP.

    Research output: Contribution to journalMeeting abstract (Journal)Research

  4. Site-specifically radiolabelled human PD-L1 nanobody: A new tool for clinical PET imaging

    Bridoux, J., Broos, K., Crauwels, M., Lecocq, Q., Martin, C., Cleeren, F., Bormans, G., Ballet, S., Raes, G., Breckpot, K., Muyldermans, S., Devoogdt, N., Caveliers, V., Keyaerts, M. & Xavier, C., May 2019, In : Journal of Labelled Compounds & Radiopharmaceuticals. 62, p. S456-S457

    Research output: Contribution to journalMeeting abstract (Journal)Research

  5. Combining Bismuth-213 with Nanobodies: Finding the Perfect Match for Targeted Alpha Therapy

    Dekempeneer, Y., Caveliers, V., D'Huyvetter, M., Maertens, D., Gysemans, M., Ooms, M., Lahoutte, T., Xavier, C., Bruchertseifer, F., Morgenstern, A. & Cardinaels, T., 23 Mar 2019, Journal of Medical Imaging and Radiation Sciences. 1 ed. Elsevier, Vol. 50. p. S7-S8 2 p.

    Research output: Chapter in Book/Report/Conference proceedingConference paperResearch

  6. The Therapeutic Potential of Anti-HER2 2Rs15d Nanobody Labeled with 225Ac – an In Vitro and In Vivo Evaluation

    Pruszyński, M., D'Huyvetter, M., Rodak, M., Dekempeneer, Y., Lahoutte, T., Cedrowska, E., Bruchertseifer, F. & Morgenstern, A., 23 Mar 2019, Journal of Medical Imaging and Radiation sciences. 1 ed. Elsevier, Vol. 50. p. S7-S7 1 p.

    Research output: Chapter in Book/Report/Conference proceedingConference paperResearch

  7. Radiometal-labeled anti-VCAM-1 nanobodies as molecular tracers for atherosclerosis - impact of radiochemistry on pharmacokinetics

    Bala, G., Crauwels, M., Blykers, A., Remory, I., Marschall, A. L. J., Dübel, S., Dumas, L., Broisat, A., Martin, C., Ballet, S., Cosyns, B., Caveliers, V., Devoogdt, N., Xavier, C. & Hernot, S., 25 Feb 2019, In : Biological Chemistry. 400, 3, p. 323-332 10 p.

    Research output: Contribution to journalArticleResearchpeer-review

  8. Next-generation muscle-directed gene therapy by in silico vector design

    Sarcar, S., Tulalamba, W., Rincon, M. Y., Tipanee, J., Pham, H. Q., Evens, H., Boon, D., Samara-Kuko, E., Keyaerts, M., Loperfido, M., Berardi, E., Jarmin, S., In't Veld, P., Dickson, G., Lahoutte, T., Sampaolesi, M., De Bleser, P., VandenDriessche, T. & Chuah, M. K., 30 Jan 2019, In : Nature Communications. 10, 1, p. 492 18 p., 492.

    Research output: Contribution to journalArticleResearchpeer-review

  9. 2018
  10. Baseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab

    Awada, G., Özdemir, I., Schwarze, J. K., Daeninck, E., Gondry, O., Jansen, Y., Seremet, T., Keyaerts, M., Everaert, H. & Neyns, B., 15 Dec 2018, In : Annals of Oncology. 29, suppl_10, 21P.

    Research output: Contribution to journalMeeting abstract (Journal)Research

Previous 1 2 3 4 5 6 7 8 ...13 Next

ID: 36386770